Showing results (41-50 of 95) with videos related to
Sort By:
Pageof 10
International Journal of Cardiology|July 17, 2012
Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trialRenato D Lopes, Jennifer A White, Pierluigi Tricoci, et al.The American Journal of Medicine|April 12, 2017
Obesity, Diabetes, and Acute Coronary Syndrome: Differences Between Asians and WhitesMasaya Koshizaka, Renato D Lopes, L Kristin Newby, et al.The American Journal of Cardiology|May 12, 2007
Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE)Pierluigi Tricoci, Eric D Peterson, Anita Y Chen, et al.Journal of the American Heart Association|December 17, 2015
Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac SurgerySean van Diepen, Pierluigi Tricoci, Mohua Podder, et al.European Heart Journal|April 1, 2017
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trialMarco Valgimigli, Francesco Costa, Yuliya Lokhnygina, et al.American Heart Journal|June 19, 2018
Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndromeTaku Inohara, Karen Pieper, Daniel M Wojdyla, et al.Journal of the American College of Cardiology|May 21, 2013
Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trendsPierluigi Tricoci, Sergio Leonardi, Jennifer White, et al.International Journal of Cardiology|April 13, 2013
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromesRenato D Lopes, Jennifer A White, Dan Atar, et al.Heart (British Cardiac Society)|April 7, 2017
Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromesJoakim Alfredsson, Benjamin Neely, Megan L Neely, et al.Journal of the American Heart Association|December 12, 2018
Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER TrialLeo Ungar, Robert M Clare, Fatima Rodriguez, et al.Pageof 10